AJ Vaccines A/S: Financial statements 2018
CVR: 37911143
Source: annual report 2018, Danish Business Authority
01/01/2018 – 31/12/2018
AJ Vaccines A/S (CVR 37911143) has filed annual accounts for 2018. In 2018, the company reported revenue of DKK 362,192,000 and a net result of DKK -244,490,000. The profit margin was -67.5%. Equity in the 2018 report amounted to DKK 903,163,000. The solvency ratio was 64.6%.
- Revenue
- DKK 362,192,000
- Gross Profit
- DKK -150,698,000
- Profit/Loss
- DKK -244,490,000
- Equity
- DKK 903,163,000
- Total Assets
- DKK 1,397,594,000
- Employees
- 0
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2018
As of December 20, 2018, Klaus Hermansen has left the board of directors of AJ Vaccines A/S.
As of December 20, 2018, Jesper Helmuth Larsen is registered as adm. dir. of AJ Vaccines A/S.
As of December 20, 2018, Klaus Hermansen has stepped down as adm. dir. of AJ Vaccines A/S.
As of December 19, 2018, Jesper Helmuth Larsen has stepped down as director of AJ Vaccines A/S.
As of September 4, 2018, Jesper Helmuth Larsen has joined the board of directors of AJ Vaccines A/S.
As of September 4, 2018, Saddam Abdulqawi Hussein Alhumaikani has joined the board of directors of AJ Vaccines A/S.
AJ Vaccines A/S has published its interim report for the period September 1, 2016 to December 31, 2017.
About AJ Vaccines A/S
AJ Vaccines A/S is a Danish company of the type Aktieselskab based in København S, founded in 2016. The company is registered under the industry Fremstilling af farmaceutiske præparater. The company was previously named Aktieselskabet af august 2016. The management consists of Ole Vahlgren. The board consists of Abdulaziz Abdulhamid Abdulrhman Albassam (chair), Mohammed Ali A Alesayi, Mustafa Nasir Farooki and Saddam Abdulqawi Hussein Alhumaikani. The company is owned by AJ Vaccines Holding ApS. The company has 499 employees (2026). In 2025, the company reported revenue of DKK 389,681,000 and a net result of DKK -483,351,000 compared with DKK -807,117,000 the year before. Equity in the 2025 report amounted to DKK 288,465,000.
